Know Cancer

or
forgot password

Lacrimal Drainage Obstruction in Gastric Cancer Patients Receiving Adjuvant S-1 Chemotherapy: A Prospective Study


N/A
18 Years
N/A
Open (Enrolling)
Both
Gastric Cancer

Thank you

Trial Information

Lacrimal Drainage Obstruction in Gastric Cancer Patients Receiving Adjuvant S-1 Chemotherapy: A Prospective Study


Inclusion Criteria:



- Patients who received curative (R0) surgery for GC

- Patients receiving adjuvant S-1 chemotherapy

- Patients with adequate major organ functions for chemotherapy

- Patient who have taken S-1 at least 7 days (for blood and tear sampling)

Exclusion Criteria:

- Patients who are not candidate for adjuvant S-1 chemotherapy

- Patients with previous history of LDO

- Patients with other opthalmologic disease who are not appropriate to be included in
this study (i.e., patients using eyedrop medication; patients with dry eye whose
tears cannot be sampled)

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

The incidence of LDO

Outcome Description:

The cumulative incidence of LDO during the 1 year after adjuvant S1 chemotherapy will be analyzed

Outcome Time Frame:

The incidence of LDO (1 year)

Safety Issue:

No

Principal Investigator

Keun-Wook Lee, M.D. & Ph.D.

Investigator Role:

Principal Investigator

Investigator Affiliation:

Department of Internal Medicine, Seoul National University Bundang Hospital

Authority:

South Korea: Institutional Review Board

Study ID:

GC-SNUBH-2010-01

NCT ID:

NCT01486472

Start Date:

November 2010

Completion Date:

December 2013

Related Keywords:

  • Gastric Cancer
  • Adjuvant chemotherapy
  • Stomach Neoplasms

Name

Location